2329 A randomized phase III study of S-1 alone versus S-1 plus immunomodulator lentinan for unresectable or recurrent gastric cancer (JFMC36–0701)

Autor: Nishikawa, K., Yoshino, S., Morita, S., Takahashi, T., Sakata, K., Nagao, J., Nemoto, H., Murakami, N., Matsuda, T., Hasegawa, H., Shimizu, R., Yoshikawa, T., Osanai, H., Imano, M., Naitoh, H., Yabe, M., Tanaka, A., Sakamoto, J., Saji, S., Oka, M.
Zdroj: In European Journal of Cancer September 2015 51 Supplement 3:S442-S442
Databáze: ScienceDirect
Externí odkaz: